This content is in French.
The gastrin-releasing peptide receptor in prostate cancer
21 mars 2024
In this review, researchers have described the potential applications of the gastrin-releasing peptide receptor in the diagnosis, prognosis and treatment of prostate cancer. The interest of this receptor is also…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Honghu Zhang et al. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Ann Med. 2024 Dec;56(1):2320301.
View the source
